Perspectives in colorectal cancer meeting. Miami, Florida. September 28-29, 2001.
Maung
K
K
Fisher
M D
MD
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D006162:Guanylate Cyclase / Q000378:metabolism; D006801:Humans; D000077146:Irinotecan; D018895:Microsatellite Repeats / Q000235:genetics; D018365:Neoplasm, Residual / Q000175:diagnosis; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D000077150:Oxaliplatin; D000074261:Receptors, Enterotoxin; D050705:Receptors, Guanylate Cyclase-Coupled; D018000:Receptors, Peptide / Q000378:metabolism
D009944:Organoplatinum Compounds; D018000:Receptors, Peptide; D000077150:Oxaliplatin; D000077146:Irinotecan; D006162:Guanylate Cyclase; D000074261:Receptors, Enterotoxin; D050705:Receptors, Guanylate Cyclase-Coupled; D002166:Camptothecin